Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Open-market sale Director sold 6,000 shares at $385.08 ($2,310,481)
  2. 4 Open-market sale Pres. Diagnostics & Genom sold 823 shares at $388.45 ($319,694)
  3. 4 Open-market sale President-Protein Sciences sold 32,933 shares at an average $380.68 ($12,537,023)
  4. 4 Open-market sale Chief Executive Officer sold 20,000 shares at $344.00 ($6,880,000)
  5. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $333.63 ($3,336,322)
  6. 4 Open-market sale Chief Executive Officer sold 5,000 shares at $308.00 ($1,540,000)
  7. 4 Open-market sale SVP - General Counsel sold 10,857 shares at an average $301.94 ($3,278,126)
  8. 4 Open-market sale Director sold 5,000 shares at $303.34 ($1,516,675)
  9. 4 Open-market sale Director sold 5,023 shares at an average $306.62 ($1,540,167)
  10. 4/A Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Financial Officer sold 10,991 shares at an average $307.95 ($3,384,680)
  12. 4/A Derivatives Options or other derivatives
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 15,375 shares (to pay taxes)
  14. 4 Open-market sale Director sold 10,000 shares at an average $301.99 ($3,019,948)
  15. 4 Open-market sale Director sold 5,000 shares at an average $300.35 ($1,501,744)
  16. 4 Open-market sale Chief Financial Officer sold 15,909 shares at an average $280.71 ($4,465,883)
  17. 4 Grant or award Director acquired 391 shares (grant or award)
  18. 4 Grant or award Director acquired 391 shares (grant or award)
  19. 4 Grant or award Director acquired 391 shares (grant or award)
  20. 4 Grant or award Director acquired 391 shares (grant or award)

Page 12 of 35 · 695 filings